tiprankstipranks
Trending News
More News >

Check-Cap Faces Nasdaq Non-Compliance Due to Share Price

Story Highlights
Check-Cap Faces Nasdaq Non-Compliance Due to Share Price

Confident Investing Starts Here:

Check-Cap ( (CHEK) ) has provided an announcement.

Check-Cap Ltd. has received a letter from Nasdaq, indicating non-compliance with the minimum bid price requirement, as its ordinary shares have fallen below the $1 threshold. The company has a 180-day compliance period until June 30, 2025, to meet the requirement by maintaining a $1 bid price for at least ten consecutive days, or face potential delisting from the Nasdaq exchange if the deficiency is not cured.

More about Check-Cap

Check-Cap Ltd. operates in the medical technology industry, focusing on the development of innovative imaging solutions. The company is primarily known for its capsule-based system designed to detect polyps before they transform into colorectal cancer, emphasizing non-invasive screening methods.

YTD Price Performance: -44.71%

Average Trading Volume: 741,748

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: $6.73M

For a thorough assessment of CHEK stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App